Trial Profile
Clinical Trials Insight: 700026804
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2007
Price :
$35
*
At a glance
- Drugs AP 5346 (Primary) ; Antineoplastics
- Indications Gastrointestinal cancer
- Focus Adverse reactions
- Sponsors Access Pharmaceuticals
- 06 Sep 2007 New trial record.